Exosomes are 50-100 nm membranous vesicles actively released by cells which can be indicative of a diseased cell status. They contain various kinds of molecule-proteins, mRNA, miRNA, lipids ¬-that are actively being studied as potential biomarkers. Hereafter I put forward several arguments in favor of the potential use of glycosylphosphatidylinositol-anchored proteins (GPI-APs) as biomarkers especially of cancerous diseases. I will briefly update readers on the exosome field and review various features of GPI-APs, before further discussing the advantages of this class of proteins as potential exosomal biomarkers. I will finish with a few examples of exosomal GPI-APs that have already been demonstrated to be good prognostic markers, as well as innovative approaches developed to quantify these exosomal biomarkers. Dear Madam, dear Sir, please, find a review entitled: 'Exosomes and GPI-anchored proteins: judicious pairs for investigating biomarkers from body fluids'. This review chiefly examines the possibility of using exosomal GPIanchored proteins regarding investigation of biomarkers. The aim is to highlight common points in proteins sorted in exosomes while drawing lessons from a cell biology standpoint. One main notion considered is that lipid domains behave as sorting devices during exosomes biogenesis. I believe that this review could be of potential interest to the readership of Advanced drug delivery reviews and more largely to the exosome community, and hope that it will be acceptable for publication. Looking forward to receiving your decision and thanking you for your consideration, Best regards,